What is Vastarel MR?

Category: Prescription Drugs


Vastarel MR is a modified release formulation of trimetazidine, a cardiovascular agent used for long-term treatment of angina pectoris. It is an international product not available in the U.S.

Reported purpose & perceived effectiveness
Purpose Patients Patients with evaluations Perceived Effectiveness
1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell


Most common dosages (by patients currently taking Vastarel MR)
Dosage Patients
70 mg daily 1
Why Patients Stopped Taking Vastarel MR (multiple reasons could be selected)
Reason Patients
Other 1
See all 1 patient who’ve stopped taking Vastarel MR


Stopped Taking Vastarel MR
Duration Patients
0-1 month 0
1-3 months 0
3-6 months 0
6 months-1 year 0
1-2 years 0
2 years or more 1
Last updated:
There are no evaluations for Vastarel MR.